S&P 500   3,360.47 (+0.27%)
DOW   27,791.44 (+1.30%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   3,360.47 (+0.27%)
DOW   27,791.44 (+1.30%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   3,360.47 (+0.27%)
DOW   27,791.44 (+1.30%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   3,360.47 (+0.27%)
DOW   27,791.44 (+1.30%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
Log in

NASDAQ:ONCESpark Therapeutics News Headlines

$113.57
0.00 (0.00 %)
(As of 12/26/2019)
Add
Compare
Today's Range
$113.57
Now: $113.57
$113.57
50-Day Range
$113.57
MA: $113.57
$113.57
52-Week Range
$34.53
Now: $113.57
$114.20
Volume8,720 shs
Average Volume419,933 shs
Market Capitalization$4.37 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.05

Headlines

Spark Therapeutics (NASDAQ ONCE) News Headlines

Source:
DateHeadline
Enzon Pharmaceuticals (OTCMKTS:ENZN) & Spark Therapeutics (OTCMKTS:ONCE) Financial AnalysisEnzon Pharmaceuticals (OTCMKTS:ENZN) & Spark Therapeutics (OTCMKTS:ONCE) Financial Analysis
www.americanbankingnews.com - July 23 at 2:45 PM
F. Hoffmann-La Roche Ltd: Roche and Spark Therapeutics, Inc. receive Request for Additional Information from FTC under HartF. Hoffmann-La Roche Ltd: Roche and Spark Therapeutics, Inc. receive Request for Additional Information from FTC under Hart
www.bloomberg.com - May 26 at 10:18 PM
Why Agile Therapeutics Stock Is Jumping TodayWhy Agile Therapeutics Stock Is Jumping Today
www.fool.com - May 4 at 5:35 PM
Spark Therapeutics Inc.Spark Therapeutics Inc.
www.barrons.com - February 26 at 12:25 PM
The Biotech Revolution: Profiting From the Future of ScienceThe Biotech Revolution: Profiting From the Future of Science
www.nasdaq.com - February 7 at 6:07 PM
F. Hoffmann-La Roche Ltd: Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of SparkF. Hoffmann-La Roche Ltd: Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark
www.bloomberg.com - February 7 at 12:13 AM
Roche Finishes Year With Big Deals, Gene Therapy In Focus As Competition Heats UpRoche Finishes Year With Big Deals, Gene Therapy In Focus As Competition Heats Up
seekingalpha.com - December 30 at 3:58 PM
Spark Therapeutics CEO: 'We get to write the next chapter'Spark Therapeutics CEO: 'We get to write the next chapter'
finance.yahoo.com - December 17 at 5:20 PM
Regulators Give Roche Green Light For $4.3B Spark Therapeutics AcquisitionRegulators Give Roche Green Light For $4.3B Spark Therapeutics Acquisition
www.msn.com - December 17 at 12:19 PM
Roche completes $4.3B purchase of Philadelphia gene therapy pioneer Spark TherapeuticsRoche completes $4.3B purchase of Philadelphia gene therapy pioneer Spark Therapeutics
www.bizjournals.com - December 17 at 12:19 PM
Roche's Small Spark Deal Holds a Big Regulatory WarningRoche's Small Spark Deal Holds a Big Regulatory Warning
finance.yahoo.com - December 17 at 12:19 PM
Roche has 60.4% of Spark, plans to wrap up takeover on TuesdayRoche has 60.4% of Spark, plans to wrap up takeover on Tuesday
www.reuters.com - December 17 at 7:19 AM
F. Hoffmann-La Roche Ltd: Roche purchases shares in tender offer for Spark Therapeutics, Inc.F. Hoffmann-La Roche Ltd: Roche purchases shares in tender offer for Spark Therapeutics, Inc.
www.finanznachrichten.de - December 17 at 1:32 AM
Roche purchases shares in tender offer for Spark Therapeutics, Inc.Roche purchases shares in tender offer for Spark Therapeutics, Inc.
www.marketwatch.com - December 17 at 1:32 AM
U.S. approves Roche-Spark mergerU.S. approves Roche-Spark merger
seekingalpha.com - December 16 at 8:31 PM
UK markets watchdog on board with Roche/Spark tie-upUK markets watchdog on board with Roche/Spark tie-up
seekingalpha.com - December 16 at 10:31 AM
F. Hoffmann-La Roche Ltd: Roche and Spark Therapeutics, Inc. announce unconditional clearance by UK Competition and Markets AuthorityF. Hoffmann-La Roche Ltd: Roche and Spark Therapeutics, Inc. announce unconditional clearance by UK Competition and Markets Authority
www.finanznachrichten.de - December 16 at 5:30 AM
Roche and Spark Therapeutics, Inc. announce unconditional clearance by UK Competition and Markets AuthorityRoche and Spark Therapeutics, Inc. announce unconditional clearance by UK Competition and Markets Authority
www.marketwatch.com - December 16 at 5:30 AM
Biotech is beating health care by double this year—heres how one investor would play itBiotech is beating health care by double this year—here's how one investor would play it
www.cnbc.com - December 10 at 8:10 AM
Make it 10: Roche again extends $4.3B bid to buy Spark TherapeuticsMake it 10: Roche again extends $4.3B bid to buy Spark Therapeutics
www.bizjournals.com - December 9 at 1:42 PM
Spark Therapeutics, Inc. Common Stock (ONCE) Earnings Report DateSpark Therapeutics, Inc. Common Stock (ONCE) Earnings Report Date
www.nasdaq.com - November 12 at 7:04 AM
Spark Therapeutics, Inc. (ONCE)Spark Therapeutics, Inc. (ONCE)
seekingalpha.com - November 7 at 6:08 PM
For the eighth time, Roche extends $4.3B tender offer for Spark TherapeuticsFor the eighth time, Roche extends $4.3B tender offer for Spark Therapeutics
finance.yahoo.com - October 29 at 4:38 PM
Will Spark Therapeutics (ONCE) Report Negative Q3 Earnings? What You Should KnowWill Spark Therapeutics (ONCE) Report Negative Q3 Earnings? What You Should Know
finance.yahoo.com - October 29 at 11:38 AM
Spark Therapeutics Wins Prix Galien USA Award for LUXTURNA(R) (voretigene neparvovec-rzyl) as Best Biotechnology ProductSpark Therapeutics Wins Prix Galien USA Award for LUXTURNA(R) (voretigene neparvovec-rzyl) as Best Biotechnology Product
www.marketwatch.com - October 25 at 12:37 PM
Spark Therapeutics Wins Prix Galien USA Award for LUXTURNA® (voretigene neparvovec-rzyl) as Best Biotechnology ProductSpark Therapeutics Wins Prix Galien USA Award for LUXTURNA® (voretigene neparvovec-rzyl) as Best Biotechnology Product
finance.yahoo.com - October 25 at 12:37 PM
Why Roche's Acquisition Of Spark May Be Complete By Year's EndWhy Roche's Acquisition Of Spark May Be Complete By Year's End
finance.yahoo.com - October 25 at 12:37 PM
FTC staff recommends approval of Roche deal for Spark: reportFTC staff recommends approval of Roche deal for Spark: report
finance.yahoo.com - October 24 at 6:43 PM
UPDATE 2-Roche lifts 2019 sales view again as Chinese demand soarsUPDATE 2-Roche lifts 2019 sales view again as Chinese demand soars
finance.yahoo.com - October 16 at 8:48 AM
Seventh time a charm? Roche extends $4.3B Spark tender offer once againSeventh time a charm? Roche extends $4.3B Spark tender offer once again
finance.yahoo.com - October 1 at 3:55 PM
Roche's (RHHBY) Rituxan Receives FDA Nod for Label ExpansionRoche's (RHHBY) Rituxan Receives FDA Nod for Label Expansion
finance.yahoo.com - September 30 at 5:20 PM
Roche extends Spark offer again as regulatory review drags onRoche extends Spark offer again as regulatory review drags on
finance.yahoo.com - September 30 at 1:51 AM
Employers Fear Squeeze From Genetic Cures That Cost MillionsEmployers Fear Squeeze From Genetic Cures That Cost Millions
www.bloomberg.com - September 12 at 12:52 PM
Gene therapy under review: Spark Therapeutics sale delayed againGene therapy under review: Spark Therapeutics sale delayed again
www.msn.com - September 3 at 9:18 PM
Companies to Watch: Roche gets more time for Spark deal, AstraZeneca shows promise in clinical trial, Snap get upgradedCompanies to Watch: Roche gets more time for Spark deal, AstraZeneca shows promise in clinical trial, Snap get upgraded
finance.yahoo.com - September 3 at 9:18 PM
$4.3B deal delayed again: Roche extends Spark Therapeutics offer for sixth time$4.3B deal delayed again: Roche extends Spark Therapeutics offer for sixth time
finance.yahoo.com - September 3 at 9:18 PM
Roche, Spark again extend $4.3 bln takeover offerRoche, Spark again extend $4.3 bln takeover offer
www.nasdaq.com - September 3 at 8:02 AM
Another extension for Roche-Spark takeover offerAnother extension for Roche-Spark takeover offer
seekingalpha.com - September 3 at 8:02 AM
Roche, Spark again extend $4.3 billion takeover offerRoche, Spark again extend $4.3 billion takeover offer
finance.yahoo.com - September 3 at 8:02 AM
Spark Therapeutics Announces Change of Location for Annual Meeting of StockholdersSpark Therapeutics Announces Change of Location for Annual Meeting of Stockholders
finance.yahoo.com - August 27 at 8:03 AM
Tender offer deadline in $4.3B Roche-Spark deal pushed back for a fifth time.Tender offer deadline in $4.3B Roche-Spark deal pushed back for a fifth time.
finance.yahoo.com - July 31 at 6:02 PM
F. Hoffmann-La Roche Ltd: Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.F. Hoffmann-La Roche Ltd: Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.
www.finanznachrichten.de - July 31 at 8:08 AM
Roche, Spark extend $4.3B takeover againRoche, Spark extend $4.3B takeover again
seekingalpha.com - July 31 at 8:08 AM
Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.
www.marketwatch.com - July 31 at 8:08 AM
Analysts Estimate Spark Therapeutics (ONCE) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Spark Therapeutics (ONCE) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - July 30 at 11:58 PM
Roche (RHHBY) 1H19 Earnings & Sales Up Y/Y, View RaisedRoche (RHHBY) 1H19 Earnings & Sales Up Y/Y, View Raised
finance.yahoo.com - July 25 at 8:48 AM
U.S. Mergers And Acquisitions: A Q2 2019 ReportU.S. Mergers And Acquisitions: A Q2 2019 Report
seekingalpha.com - July 15 at 8:55 AM
Sangamo Up As Gene Therapy Shows Promise in Hemophilia Study (Revised)Sangamo Up As Gene Therapy Shows Promise in Hemophilia Study (Revised)
finance.yahoo.com - July 11 at 8:01 AM
Blood pact: Roche-Spark deal deadline pushed back as regulators check impact on prices, availabilityBlood pact: Roche-Spark deal deadline pushed back as regulators check impact on prices, availability
www.msn.com - July 10 at 8:02 AM
Roche, Spark push back takeover deadline in $4.3 bln dealRoche, Spark push back takeover deadline in $4.3 bln deal
www.nasdaq.com - July 8 at 7:14 PM
This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.